Type:Injection
Generic Name:Nandrolone
Manufacturer:Chemist Laboratories Ltd.
Price:৳0.00
Postmenopausal osteoporosis, Metastatic breast cancer, Anaemia of chronic renal failure, Anaemia in chemotherapy patients
Intramuscular As anabolic after debilitating illness; Postmenopausal osteoporosis; Metastatic breast cancer Adult: As decanoate: 25-100 mg once every 3-4 wk. Anaemia of chronic renal failure Adult: As decanoate: 50-200 mg wkly. Anaemia in chemotherapy patients Adult: 50-150 mg wkly.
Prostatic or breast carcinoma (male); nephrosis, porphyria; infants, pregnancy and lactation.
Nandrolone is an anabolic steroid. It promotes tissue-building processes and protein anabolism. It also stimulates erythropoeitin production, causing an increase in haemoglobin and RBC volume.
Monitor diabetic patients carefully. Conditions influenced by oedema (e.g. CV disease, migraine, seizure disorder, renal impairment). Hepatic impairment. Elderly. Discontinue if signs of virilisation in women occur. Monitor skeletal maturation in children.
Male: Postpubertal: Acne, gynaecomastia, bladder irritability, priapism, insomnia, chills, decreased libido, hepatic dysfunction, nausea, diarrhoea, prostatic hyperplasia. Prepubertal: Acne, virilism, chills, insomnia, hyperpigmentation, diarrhoea, nausea. Female: Virilism, hypercalcaemia, nausea, diarrhoea, chills, insomnia, iron deficiency anaemia, hepatic dysfunction.
May increase effects of oral anticoagulants, insulin, oral antidiabetic agents, adrenal steroid, adrenocorticotropic hormone (ACTH).
